Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial

Within a randomized phase II setting, results observed with addition of dB to T-based chemotherapy in RR-HR-NB warrant further evaluation.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-12-12
DOI
https://doi.org/10.1200/jco-25-01868
Citations
1
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial

Dave Hobin, Nadège Corradini, G.A. Amos Burke, Ruth Lydia Ladenstein et al.
1 citations
Journal of Clinical Oncology
Neuroblastoma Research and Treatments
1.39
article

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial

Dave Hobin, Nadège Corradini, G.A. Amos Burke, Ruth Lydia Ladenstein, Grace Holt, Soledad Gallego, Aurora Castellano, Dominique Valteau‐Couanet, C. Michel Zwaan, Keith Wheatley, Antony Ng, Juliet C. Gray, Adela Cañete, Martin Elliott, Charlotte Firth, Guy Makin, Nicolas U. Gerber, Jennifer Laidler, Estelle Thébaud, Anne Sophie Defachelles, Lisa Howell, Marion Gambart, Sucheta Vaidya, Cormac Owens, Andrew D.J. Pearson, Deborah A. Tweddle, Pamela R. Kearns, Sally L. George, Bénédicte Brichard, Bram De Wilde, Anthony McCarthy, Natasha K. A. van Eijkelenburg, Louis Chesler, Rebekah Weston, Sarah Jannier, Ricardo López Almaraz, Alba Rubio‐San‐Simón, Lynley V. Marshall, Karsten Nysom, Gudrun Schleiermacher, Giuseppe Barone, Simon Gates, Lucas Moreno, V. V. Moroz, Dermot Murphy, Dan Yeomanson
article en
1 citations

Abstract

Within a randomized phase II setting, results observed with addition of dB to T-based chemotherapy in RR-HR-NB warrant further evaluation.

Journal of Clinical OncologyVol. 44(3)
Leeds General Infirmary (GB), Cliniques Universitaires Saint-Luc (BE), Institute of Cancer Research (GB), University of Liverpool (GB), Great Ormond Street Hospital (GB), Royal Victoria Infirmary (GB), Al Jalila Foundation (AE), Royal Belfast Hospital for Sick Children (GB), Institut Gustave Roussy (FR), Bristol Royal Hospital for Children (GB), Copenhagen University Hospital (DK), Rigshospitalet (DK), Centre Hospitalier Universitaire de Nantes (FR), BioCruces Health research Institute (ES), Birmingham Women's Hospital (GB), Hôpital d'Enfants (FR), Centre Léon Bérard (FR), Hospital Infantil Universitario Niño Jesús (ES), Royal Marsden Hospital (GB), Bambino Gesù Children's Hospital (IT), St Anna Children's Hospital (AT), Universitair Ziekenhuis Brussel (BE), Princess Máxima Center (NL), Vall d'Hebron Hospital Universitari (ES), University Children's Hospital Zurich (CH), Centre Oscar Lambret (FR), Cancer Research UK Clinical Trials Unit (GB), Our Lady's Hospital (IE), Erasmus MC - Sophia Children’s Hospital (NL), Hôpital des Enfants (FR), Hôpital d'Hautepierre (FR), Alder Hey Children's Hospital (GB), Royal Manchester Children's Hospital (GB), NIHR Birmingham Biomedical Research Centre (GB), Sheffield Children's Hospital (GB), Instituto de Investigación Sanitaria La Fe (ES), University of Southampton (GB), University College London (GB), University of Birmingham (GB), Institut Curie (FR)
Solving Kids' Cancer, Cancer Research UK, EUSA Pharma
Openalex Percentile: Top 13%
Neuroblastoma Research and Treatments
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.